Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study supports role of aspirin in reducing risk of colorectal cancer

03.02.2004


More research needed to identify those for whom benefit could outweigh risk of side effects



A new study has found that regular intake of aspirin does appear to be associated with a reduced risk of the type of colon polyps that can develop into cancer. However, since risk reduction was strongest with aspirin doses higher than those used to prevent cardiovascular disease, the researchers say further study is needed to determine for whom the benefits of such treatment would outweigh any potential risks. The report – from researchers at Massachusetts General Hospital (MGH), Brigham and Women’s Hospital and affiliated institutions – appears in the February issue of Annals of Internal Medicine.

"We would love to have a simple, daily tablet that could reduce the risk of colorectal cancer for everyone, but right now we don’t have that," says Andrew Chan, MD, of the MGH Gastrointestinal Unit, the paper’s lead author. "However, confirming that aspirin, especially at higher doses, may reduce cancer risk is very exciting and opens many avenues of research for better understanding the mechanism of this disease."


Earlier studies at a number of centers suggested that aspirin could reduce the risk of colorectal polyps but had not established the most effective dose. The current investigation is part of the Nurses Health Study, which has followed more than 120,000 female registered nurses since the mid-1970s, asking them to complete a questionnaire on risk factors for cancer and cardiovascular disease every two years. In 1980, assessments of diet, aspirin use, and colon examination were added to the NHS questionnaire.

The report in Annals examines data from about 27,000 Nurses Health Study participants, ages 34 to 77 with no history of cancer, who reported having endoscopic colon examinations between 1980 and 1998. Among that study group, almost 1,400 participants were diagnosed with adenoma – a type of colorectal polyp that may develop into cancer – during the 18-year period.

Participants who reported taking aspirin regularly had a 25 percent lower risk of adenoma than did women who took no aspirin, with the lowest risk seen among those who took more than two standard aspirin tablets per day. Current guidelines for heart disease prevention suggest that low doses – one baby aspirin tablet per day – are as effective as higher doses. The authors caution that high doses of aspirin have been shown to pose a greater risk of side effects such as bleeding.

"Before these findings can be translated into clinical recommendation, we need better ways of identifying exactly who should take aspirin to reduce colorectal cancer risk," says Chan, a research fellow at Harvard Medical School. "Other potential risk factors or genetic markers could be associated with levels of benefit that might outweigh the risks posed by higher doses of aspirin. Until those questions are answered, people should follow current screening recommendations, which are proven to save lives."

Additional authors of the study are Charles Fuchs, MD, MPH, senior author, of Dana-Farber Cancer Institute and Brigham and Women’s Hospital (BWH); Edward Giovannucci, MD, ScD, Eva Schernhammer, MD, DrPH, Graham Colditz, MD, DrPH, and David Hunter, MD, ScD, all of BWH and the Channing Laboratory at Harvard Medical School; and Walter Willett, MD, DrPH, of BWH and Harvard School of Public Health. The research was supported by grants from the National Institutes of Health.

The Nurses’ Health Study (NHS) was initiated in 1976 at BWH. The NHS is the longest-running, major women’s health study ever undertaken and has resulted in hundreds of journal articles, many containing groundbreaking findings on how to prevent some of the major causes of disease and death in women.


Massachusetts General Hospital, established in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $350 million and major research centers in AIDS, cardiovascular research, cancer, cutaneous biology, medical imaging, neurodegenerative disorders, transplantation biology and photomedicine. In 1994, MGH and BWH joined to form Partners HealthCare System, an integrated health care delivery system comprising the two academic medical centers, specialty and community hospitals, a network of physician groups, and nonacute and home health services.

Sue McGreevey | EurekAlert!
Further information:
http://www.mgh.harvard.edu/

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Gold shines through properties of nano biosensors

17.08.2017 | Physics and Astronomy

Greenland ice flow likely to speed up: New data assert glaciers move over sediment, which gets more slippery as it gets wetter

17.08.2017 | Earth Sciences

Mars 2020 mission to use smart methods to seek signs of past life

17.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>